Our mission is quite simple, to address a major unmet need in Alzheimer’s - Screening. Screening for disease risk enables early detection and mitigation driving the right people to diagnosis, therapy or prevention.
ALZAI is the first AI-driven Alzheimer’s Disease risk screening platform using non-invasive, low-cost, pre-existing biomarker data, providing early detection and improving patient outcomes.
Identifies Alzheimer’s disease risk up to 10 years before symptoms appear, enabling earlier intervention and better patient outcomes.
Proven effectiveness with over 500,000 diverse patients, demonstrating unparalleled and reliable screening capabilities.
Delivering Non-Invasive, low-cost screening solution enabling Alzheimer’s screening for entire patient populations.
Built on a use -friendly, easily integrated platform for healthcare providers, clinical researchers, and stakeholders to engage ALZAI Screening.
Our mission is quite simple, to address a major unmet need in Alzheimer’s - Screening. Screening for disease risk enables early detection and mitigation driving the right people to diagnosis, therapy or prevention.
In a perfect world, everyone over 50 would be screened for Alzheimers Disease. ALZAI can assess risk of developing disease, ushering in the pre-Alzheimers & designation, enabling preventative care. ALZAI would also detect for more early stage disease, enabling more people to be diagnosed early, enabling earlier intervention - when therapies work best.
Sensitivity detecting who will be diagnosed with Alzheimer’s.
Screening for disease risk up to 10 years out.
More sensitive than existing screening methods.
Biomarkers used, present in common medical records.
Real world patient medical records trained with AI.
Sensitivity detecting who will be diagnosed with Alzheimer’s.
Screening for disease risk up to 10 years out.
More sensitive than existing screening methods.
Biomarkers used, present in common medical records.
Real world patient medical records trained with AI.
Director, CEO & Co-founder
Director, CRO & Co-founder
Director, CMO & Co-founder
Director, Data Science Lead & Co-founder
Advisor
Advisor
Advisor
Advisor